Evaluation of the end-stage renal disease treatment choices model and the kidney care choices model
Active Awarded Last action
- Contract number
- 75FCMC22F0001
- Awardee
-
The Lewin Group, Inc. UEI KRVRMDJKAA16 Part of Unitedhealth Group Incorporated
- Awarding agency
-
Centers for Medicare and Medicaid Services
Department of Health and Human Services
- Obligated
- $24,471,623
Award facts
- Contract value 100% obligated
- $24,471,623.00 Current and potential, with all options
- Completion date 62% complete
- Current and potential, with all options
- NAICS code
- 541720 Research and Development in the Social Sciences and Humanities
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Windsor Mill, Milford Mill, MD 21244, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $7,910,029 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | -$4,755,837 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $21,317,431 |
Show all 11
About this award
The Centers for Medicare and Medicaid Services (CMS) awarded a delivery order valued at approximately $24.5M to The Lewin Group, Inc., a UnitedHealth Group subsidiary, on February 25, 2022. The contract, which extends through August 2029, supports the Research, Measurement, Assessment, Design, and Analysis (RMADA) 2 program and requires an independent evaluation of two kidney disease treatment models: the End-Stage Renal Disease Treatment Choices Model (ETC) and the Kidney Care Choices Model (KCC). The work will be performed at The Lewin Group's facility in Windsor Mill/Milford Mill, Maryland. No set-aside designation was used for this award, indicating full and open competition.
This delivery order is issued under the RMADA 2 indefinite delivery vehicle and leverages The Lewin Group's extensive expertise in healthcare program evaluation and evidence-based research. As a leading health care and human services consulting firm, The Lewin Group regularly provides evaluation services and technical assistance to federal health agencies, making it well-positioned to conduct rigorous assessments of innovative renal disease treatment models. The work contributes to CMS's broader mission of evaluating new care delivery and payment models designed to improve patient outcomes and inform evidence-based policy decisions in Medicare's end-stage renal disease treatment programs.
Quick answers
Who was awarded contract 75FCMC22F0001?
75FCMC22F0001 was awarded to The Lewin Group, Inc. by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on February 25, 2022.
How much is contract 75FCMC22F0001 worth?
The government has obligated $24,471,623 on 75FCMC22F0001.
Is contract 75FCMC22F0001 an order under another contract?
Yes. 75FCMC22F0001 is a delivery order under 75FCMC19D0096, an indefinite delivery contract, on Research, Measurement, Assessment, Design, and Analysis 2 (RMADA 2).
Was contract 75FCMC22F0001 competed?
The extent of competition for 75FCMC22F0001 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award